Fludarabine and melphalan results in fewer relapses compared to fludarabine and targeted busulfan in patients receiving reduced intensity conditioning for AML and MDS

This article has no abstract
Epistemonikos ID: 92b3de479a3e206a5e19afddc6d59ed13e38c61d
First added on: Feb 08, 2025